LOS ANGELES, Sept. 2 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN)
announced earlier today that breaking news will be issued tomorrow, at the
opening of the market, regarding the law firm of Vianale & Vianale, and
others.
About Signalife
Signalife, Inc. is a life sciences company focused on the monitoring,
detection and prevention of disease through continuous biomedical signal
monitoring. Signalife uses its patented signal technology to design and
develop medical devices, therapies and/or technologies that simplify and
reduce the costs of cardiovascular disease.
Signalife, Inc. is traded on the American Stock Exchange under the symbol
SGN. More information is located at www.signalife.com. Clear Data. Trusted
Results.
Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are
'forward- looking' statements. Forward-looking statements involve known and
unknown risks, which may cause the companies' actual results in the future to
differ materially from expected results. Factors which could cause or
contribute to such differences include, but are not limited to, failure to
complete the development and introduction of heart monitoring and other
biomedical devices incorporating the companies' technology procure market
acceptance for these products, failure to obtain federal or state or
governmental or international regulatory approvals governing heart monitoring
and other biomedical devices incorporating the technology, failure to obtain
import and export capabilities in the various countries containing buyers and
resellers and hospitals and clinics and doctors for the devices, inability to
obtain physician, patient or insurance acceptance of or for heart monitoring
and other biomedical incorporating of the technologies, and the unavailability
of financing to complete management's plans and objectives, including the
development of heart monitoring and other biomedical and information solutions
incorporating the company's technology. These risks are qualified in their
entirety by cautionary language and risk factors set forth and to be further
described in Signalife's filings with the Securities and Exchange Commission.
SOURCE Signalife, Inc.
